Please assess the completion status of the following clinical trial:

Trial Title: Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age more than 18 years~* CAPD initiation more than 4 weeks~Exclusion Criteria:~* Exit site or tunnel infection~* Sepsis~* Previous CAPD-associated peritonitis treatment within 4 weeks~* Drug allergy to cephalosporin~* Tenckhoff catheter malfunction~* Hospitalization more than 48 hours~* Fungal or Mycobacterium infection~* Suspected secondary peritonitis~* Concomitant antibiotics.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Cefepime intraperitoneal continuous dosing
- Control (Type: ACTIVE_COMPARATOR): Cefazolin plus Ceftazidime intraperitoneal continuous dosing

Based on this trial design, predict the completion outcome and termination type (if applicable).